interacts with p53 and modulates its transcriptional activity, but the involvement of separase is thought to be unlikely 25 . Judging from the well-conserved cleavage of cohesin, requirement of separase in DNA repair may be general in eukaryotes.
Why is cut2 EA2 normal in chromosome segregation, whereas it is hypersensitive to ultraviolet irradiation, at 26 8C? Separase was previously shown to accumulate in the mitotic nucleus, but it is sparse in the interphase nucleus 7 . Such mitosis-specific accumulation may insure that excess separase activity is available to support the fast proteolysis in anaphase. In cut2
EA2 , the accumulation mechanism should be intact, but separase in the interphase nucleus after irradiation should be meagre, leading to slow repair. A similar situation may explain the condensin cnd2-1 mutant 26 . A
Methods

Strains, plasmids and media
All S. pombe strains used were derived from haploid h 2 972 and h þ 975. Complete YPD and minimal EMM2 media were used. Thiamine (2 mM) was added to repress the nmt1 promoter. The mutated cut2 gene (designated EA2) was constructed by site-directed mutagenesis. For construction of the cut2 EA2 strain, the mutated cut2 EA2 gene was introduced together with the nmt1 þ 3 0 non-coding region and ura4 þ gene into the endogenous cut2 locus of diploid strain (h þ /h 2 leu1/leu1 his7/his7 ura4/ura4 ade6-M210/ ade6-M216). Correct integration was confirmed by genomic Southern hybridization. Resulting heterozygous diploids were sporulated, and a Ura þ haploid strain was backcrossed. The mutated rad21 genes were cloned into the pFA6a-KanMX6 derivative plasmid, followed by the integration onto the endogenous rad21 locus. An inducible promoter REP41 was used for moderate overexpression of Rad21 WT and Rad21
RREE
. The selection markers for multicopy plasmids were the Saccharomyces cerevisiae LEU2 gene or the S. pombe aur1 R gene (TaKaRa). Other strains used were described previously [9] [10] [11] 16, [18] [19] [20] 22, 27 .
Immunochemistry
Cell extracts were prepared using glass beads in KB buffer (25 mM Tris-HCl at pH 7.5, 15 mM EDTA, 60 mM b-glycerophosphate, 0.1% NP-40, 10% glycerol, 1 mM phenylmethylsulphonyl fluoride, 2 mg ml 21 pepstatin A and 1 mg ml 21 aprotinin) or 10% trichloroacetic acid. Cell extracts were boiled in LDS sample buffer (Invitrogen). Immunoblotting was performed using the following antibodies: anti-Cut1 (ref. 28) , anti-HA 16B12 (Babco) and anti-Rad21 (T. Tomonaga, unpublished). The immunoprecipitation procedure was performed as described previously 22 .
Other techniques
Ultraviolet irradiation and detection of thymine dimers were performed as previously described 29 . For quantification of dot blots, the intensity was measured by GS-250 Molecular Imager (BioRad), with calibration using serial dilutions of the 0-time-point DNA. The X-ray and g-ray apparatuses used were a RadioFlex RF-350 (Rigaku Denki) with the dose rate of 32.6 Gy min 21 and a Gammacell 40 Exactor (MDS Nordion) with the dose rate of 1.245 Gy min 21 , respectively. For the synchronous culture, a Beckman elutriator rotor (J-6M/E) was used to centrifuge exponentially growing cells (1.5 £ 10 10 ) at 26 8C, and small cells (7 £ 10 8 ) were collected and grown in YPD medium at 26 8C. Lipid transfer proteins are important in membrane vesicle biogenesis and trafficking, signal transduction and immunological presentation processes [1] [2] [3] . The conserved and ubiquitous mammalian glycolipid transfer proteins (GLTPs) serve as potential regulators of cell processes mediated by glycosphingolipids, ranging from differentiation and proliferation to invasive adhesion, neurodegeneration and apoptosis 4, 5 . Here we report crystal structures of apo-GLTP (1.65 Å resolution) and lactosylceramide-bound (1.95 Å ) GLTP, in which the bound glycosphingolipid is sandwiched, after adaptive recognition, within a previously unknown two-layer all-a-helical topology. Glycosphingolipid binding specificity is achieved through recognition and anchoring of the sugar-amide headgroup to the GLTP recognition centre by hydrogen bond networks and hydrophobic contacts, and encapsulation of both lipid chains, in a precisely oriented manner within a 'moulded-to-fit' hydrophobic tunnel. A cleft-like conformational gating mechanism, involving two interhelical loops and one a-helix of GLTP, could enable the glycolipid chains to enter and leave the tunnel in the membrane-associated state. Mutation and functional analyses of residues in the glyco- Figure 1 Overall structures of apo-GLTP and the lactosylceramide-GLTP complex. a, Stereo view of the apo-protein in a ribbon representation. Four a-helices on the front face are coloured grey, and four other a-helices on the back face are coloured brown. b, A view of apo-GLTP: a-helices (coloured gold) are shown in a cylinder representation; 3 10 helices (coloured silver) and loop segments (coloured gold) are shown in a ribbon representation. c, Chemical formula of lactosylceramide. d, e, Two perpendicular views of the lactosylceramide-GLTP complex, with a-helices (coloured gold) in a cylinder representation, 3 10 helices (coloured silver) and loop segments (coloured gold) in a ribbon representation, and bound lactosylceramide in a space-filling representation. The bound glycolipid atoms are coloured lavender, red and blue for carbon, oxygen and nitrogen atoms, respectively. f, g, Views (corresponding to d and e) of the crystallographic B-factors for the lactosylceramide-GLTP complex. The B-factor scale is colour coded as follows: blue-green, B , 34; orange, 34 , B , 46; red, B . 46.
lipid recognition centre and within the hydrophobic tunnel support a framework for understanding how GLTPs acquire and release glycosphingolipids during lipid intermembrane transfer and presentation processes.
GLTPs are soluble proteins discovered initially in the membranefree cytosolic extract of bovine spleen, and later in a wide variety of tissues, that selectively accelerate the transfer of glycolipids between membranes [6] [7] [8] . The 23-24-kDa GLTPs display absolute specificity for glycolipids 9 and are highly conserved among mammals 10 , with some orthologues implicated in apoptosis 11, 12 . Although specific folding motifs and lipid-binding domains have been characterized in other lipid transfer/binding proteins [13] [14] [15] [16] [17] [18] [19] , this is not true of GLTP. We have solved the structure of apo-GLTP crystal from human skin fibroblasts at 1.65 Å resolution and the corresponding lactosylceramide-GLTP complex co-crystal at 1.95 Å resolution (see Methods and Supplementary Table S1 ). The novel protein folding of apo-GLTP (Fig. 1a, b ) is organized as a two-layer arrangement of a-helices, with helices 1, 2, 6 and 7 forming the front layer, and helices 3, 8, 4 and 5 belonging to the back layer (Supplementary Fig. S1 ), with two long a-helices, 8 and 4, coiling around each other to form a superhelix. Such a sandwich topology generates a lactosylceramide-binding site between the a-helical layers in the lactosylceramide-GLTP complex (Fig 1d, e; Supplementary  Fig. S2a, b) .
Lactosylceramide (Fig. 1c) binding to GLTP is achieved through recognition and anchoring of the hydrophilic headgroup to the protein surface, and through accommodation of the hydrophobic lipid chains within the interior of the protein. The lactosyl headgroup is anchored within the GLTP recognition centre, located on the protein surface, through a network of hydrogen-bonding (with Asp 48, Asn 52 and Lys 55 of a2, and Tyr 207 towards the carboxy terminus) and hydrophobic (Trp 96 of a4 stacks over the glucose ring, whereas Leu 92 contacts the galactose ring) interactions ( Fig. 2a; Supplementary Fig. S3 ), analogous to carbohydrate-lectin interactions 20, 21 . The ceramide amide group is oriented through a pair of hydrogen bonds (with negatively charged Asp 48 and positively charged His 140), whose alignment is facilitated by hydrophobic contacts (with Val 209) of the initial three-carbon ceramide segment ( Fig. 2a; Supplementary Fig. S3 ). The importance of individual recognition events within the headgroup recognition centre was probed by point mutation studies, as monitored by glycolipid intervesicular transfer assays with radiolabelled glycolipid (Supplementary Fig. S4 ). The experimental data support the key role of Trp 96, His 140, Asp 48 and Asn 52 for recognition of the glycosyl and ceramide amide moieties in the complex. Mutations W96A and H140L resulted in almost complete inactivation (residual activity 1-3%), whereas mutations D48V and N52I resulted in significant inactivation (residual activity about 15%) (Fig. 2d, top) . The extent of inactivation is different for the W96F mutation (residual activity 63%) relative to its W96A counterpart (residual activity 1%), highlighting the importance of aromatic ring stacking over the glucose ring to recognition (Fig. 2d, top) . By contrast, Tyr 207 and Lys 55, which form single intermolecular hydrogen bonds, seem to be much less crucial for recognition, because the mutations Y207L and K55I retain practically full (90-97%) activity (Fig. 2d, top) . We have verified the integrity of our GLTP headgroup mutants for unanticipated structural alterations. The crystal structure of the D48V mutant shows only local rearrangements ( Supplementary Fig. S5 ), whereas circular dichroism (CD) spectra of other mutants indicate minimal perturbation of a-helical global folds (far-ultraviolet CD; Supplementary Fig. S6 , top) and of aromatic amino acid environments (near-ultraviolet CD; Supplementary Fig. S7, top) .
When GLTP acquires lactosylceramide, both hydrocarbon chains of the ceramide moiety become buried within a single completely hydrophobic tunnel, lined by the side chains of nonpolar phenylalanine, leucine, isoleucine and alanine residues, together with a few valine and proline residues (Fig. 2c) . Residual activities ranging from 50% to 90% were observed when individual phenylalanines were replaced by serines at positions 103, 148 and 183 (Fig. 2d,  bottom) , indicative of a possible additive role in creating the favourable hydrophobic environment for the nonpolar chains. Significant retention of activity (82%) was also found for the I45N mutant (Fig. 2d, bottom) , located near the entrance to the channel. Replacement of leucines by arginines affected activity differently depending on their location within the channel. Thus, the L165R, mutant located towards the end of the channel, retained 54% of activity, whereas L136R, located in the interior of the channel, retained only 5% of activity (Fig. 2d, bottom) . We have verified the integrity of the GLTP channel mutants by recording the far-ultraviolet and near-ultraviolet CD spectra (Supplementary Figs S6 and S7, bottom panels).
Neither the hydrophobic tunnel nor lipid chains (a D9,10 cisdouble bond occurs halfway down the N-acyl chain) are straight in the complex (Figs 1d, e and 2c) . The N-acyl chain extends deeper into the hydrophobic tunnel because it is longer than the adjacent sphingoid-base chain (Fig. 1c, d ). The terminal segments of both chains become nearly orthogonal with respect to the long axis of the sphingoid base (Figs 1d and 2c ). Our measured solvent-accessible volume of about 315 Å 3 for the lipid-binding tunnel in the complex is much smaller than reported values for other lipid-binding pockets 19 , indicative of a very tight fit between the inserted portion of the lipid chains, with an estimated volume of about 330 Å 3 , and the walls of the tunnel. The measured solvent-accessible volume is further reduced to 170 Å 3 in apo-GLTP, so that this residual space can no longer accommodate lipid chains.
Our structure of the lactosylceramide-GLTP complex (1.95 Å ) can be compared with the structures of the ganglioside GM2-CD1b (2.8 Å ) 16 and sulphated-galactosylceramide-CD1a (2.15 Å ) 17 complexes. The recognition specificity associated with the network of hydrogen-bonding interactions involving the glycosyl and ceramide moieties distinguishes the GLTP complex (Fig. 2a) from the corresponding CD1a complex, which involved far fewer hydrogenbonding recognition contacts 17 . Further, whereas the dual-chain lipid inserts into a common hydrophobic tunnel in the GLTP complex (Fig. 2c) , the sphingoid-base and N-acyl chains insert into separate interconnecting hydrophobic pockets in the CD1a complex 17 . It therefore seems that unique glycolipid-protein inter- Figure 3 Comparison of apo-GLTP and lactosylceramide-bound GLTP. a, Superposition of apo-GLTP and lactosylceramide-bound GLTP structures, with similarly positioned a-helices shown in a cylinder representation, while 3 10 helices and loop segments are coloured orange for free GLTP and white for lactosylceramide-bound GLTP. Note the similarity of the glycosyl recognition centre conformations (top centre) and differences in the structure of the a1-a2 loop, and in mutual positioning of the a6-helix and the N terminus of the a2-helix. actions are associated with distinct functional events, namely glycolipid transfer in the GLTP complex in contrast to glycolipid presentation in the CD1b 16 and CD1a 17 major histocompatibility complexes.
Superposition of the apo-GLTP and lactosylceramide-bound GLTP structures reveals essentially no difference in the headgroup recognition centre but provides clear evidence of localized conformational differences related to the hydrophobic channel (Fig. 3a) . The differences, positioned along the front layer of GLTP, are associated with interhelical loops a1-a2 and a6-a7, helix a6 and the amino terminus of helix a2 (Fig. 3b, c) . The conformational consequences of glycolipid acquisition are: first, bending of the a2-helix; second, rearrangement of the a1-a2 loop, accompanied by the appearance of a new 3 10 helix near the N terminus of the a2 helix; third, outward displacement of the a6 helix by 2.7 Å ; and fourth, shortening of the C terminus of the a6 helix that is compensated for by formation of a new 3 10 helix (Figs 1b, d and 3a (Fig. 3b, c) , while the side chains of Phe 148 and Leu 152 rotate around their Ca-Cb bonds to move from an inside-facing orientation in apo-GLTP (Fig. 3b) to a swung-out orientation in lactosylceramide-bound GLTP (Fig. 3c) . The net result of all movements and rearrangements is an opening and expansion of a hydrophobic tunnel (Fig. 3d, e) when GLTP acquires the lactosylceramide molecule from the membrane.
It is difficult to imagine penetration of the lipid chains into the protein interior via an 'end-on digging or tunnelling mechanism' (pushing the hydrophobic walls apart to get the terminal methyl groups buried deeper and deeper). Rather, the GLTP structure most probably provides a cleft-like gate, which could open and close to let the lipid chains in and out. Indeed, the crystallographic B-factor distribution reveals local conformational mobility within the lactosylceramide-bound GLTP (Fig. 1f, g; highest B-factors in red). A comparative analysis for apo-GLTP and lactosylceramide-bound GLTP structures suggests that the loops a1-a2 and a5-a6, helix 6 and possibly helix 7 could form the lipid 'gate' in GLTP. The proper orientation of the glycolipid recognition centre and the 'gate' region with respect to the membrane surface might be aided by Trp 142 as well as Tyr 81, Tyr 153, Tyr 157 and Tyr 207, nearby residues known to interact favourably with membrane interfaces 22, 23 . The GLTP-membrane interface could potentially provide a favourable environment for protein conformational changes that enhance the binding and desorption of glycolipid amphiphiles from the membrane into GLTP.
To our knowledge, the results on apo-GLTP and lactosylceramide-bound GLTP are the first demonstration of a two-layered a-helical motif functioning to accommodate a glycolipid by the creation and expansion of a 'moulded-to-fit' hydrophobic tunnel (Fig. 3e ) that does not pre-exist in the free protein (Fig. 3d) . This architecture differs from all previously reported motifs of lipidbinding and lipid-transfer proteins, which are either a-helical with extensive disulphide crosslinking or contain extensive b-structure. Thus, GLTP represents a new emerging family of sphingolipidbinding/transfer proteins. Our results provide a potential framework for understanding how GLTPs, with their structurally conservative and conformationally flexible segments, acquire and release membrane glycolipids during lipid transport and presentation processes.
A
Methods
Plasmid construction and mutagenesis
The open reading frame encoding human GLTP (NCBI GenBank accession no. AF209704) was subcloned into the pET-30 Xa/LIC expression vector (Novagen) by ligationindependent cloning, resulting in N-terminal His tags and S-tags and a factor Xa cleavage site. Site-directed mutations were obtained with a QuickChange site-directed mutagenesis kit (Stratagene).
Protein expression and purification
Transformed BL21 (DE3) cells (Novagen) were grown in Luria-Bertani medium at 37 8C, induced with 0.1 mM isopropyl b-D-thiogalactoside and grown for a further 16-20 h at 15 8C. Purification of recombinant GLTP (rGLTP) from soluble lysate protein was accomplished by Ni-affinity chromatography. The His-tag and S-tag sequences were removed from rGLTP by using factor Xa. rGLTP was then purified by fast protein liquid chromatography size-exclusion chromatography. Selenomethionine (Se-Met)-labelled GLTP, incorporated by inhibiting the methionine biosynthesis pathway 24 , retained full activity. Point mutants of the liganding site (Fig. 2d) had similar high yields and solubilities to those of the wild-type protein, consistent with folding to native-like conformations. In contrast, point mutations of essential residues in connecting regions between helices and far removed from the liganding site (for example W85-cis-P86 ( Supplementary Fig. S8b ), W85R), resulted in inactive protein, characterized by poor yield and very low solubility during expression and consistent with global folding changes.
Activity of rGLTP
The glycolipid transfer activity of GLTP was measured by using established radiolabelled assays. Negatively charged donor vesicles containing tritiated galactosylceramide (2 mol%) were incubated with GLTP (1 mg) and a tenfold excess of neutral acceptor vesicles at 37 8C. Quantification of glycolipid transfer was achieved by liquid scintillation counting of acceptor vesicles recovered from DEAE minicolumns 8, 12 .
Crystallization and X-ray data collection
Crystals of GLTP were grown by the hanging-drop vapour-diffusion method. Protein samples (7-15 mg ml 21 ) were mixed with equal amount of well solution (15-20% (w/v) PEG 3350, 50 mM KH 2 PO 4 pH 4.5). For Se-Met-GLTP, 10 mM dithiothreitol was included in crystallization reagents. Single crystals appeared in 2-5 days at room temperature. GLTP-glycolipid crystal complexes were obtained by co-crystallization of protein with lactosylceramide (0.4 mM in 50% ethanol). The crystals appeared in 2-3 months. Lactosylceramide, which contained homogeneous oleoyl (C 18:1 ) acyl chains, was synthesized and purified as described previously 25 . Crystals were transferred into well solution including 20% glycerol as cryoprotectant, then mounted in a fibre loop and flashfrozen in a cold nitrogen stream for X-ray data collection.
Structure determination and refinement
Crystallization of apo-GLTP and its selenomethionine derivative was achieved in space group P2 1 with similar unit cell parameters and with one protein molecule in the asymmetric unit (Supplementary Table S1 ). The crystal structure of GLTP was determined by the multiwavelength anomalous dispersion method 26 . Five of the six selenium sites were identified and refined by the SOLVE/RESOLVE package 27 . The resulting electron density map was calculated after automatic maximum-likelihood density modification in SOLVE/RESOLVE. On the basis of this map, most of the protein chain was traced with the ARP/wARP program 28 . The protein model was finally built through several cycles of manual model building with TURBO. The model was refined in REFMAC 29 at 1.65 Å resolution against the native data set to a final Rfactor/R-free of 0.171/0.224 (Supplementary Table S1 ). The automatic procedure ARP/ wARP was used to add solvent molecules to a final model. Two examples of the electron density map ( Supplementary Fig. S8a, b) indicate the high quality of the final model. The distribution of secondary structure elements along the GLTP amino-acid sequence is shown in Supplementary Fig. S8c . The final model contains two disordered regions (1-7 and 168-171). Database searches with the SCOP (http://scop.mrclmb.cam.ac.uk/scop) and DALI (http://www.ebi.ac.uk/dali) programs revealed no structural similarity between the helical sandwich topology of apo-GLTP and deposited protein topologies.
Co-crystallization of GLTP with lactosylceramide was achieved in space group C2 with one molecule in the asymmetric unit (Supplementary Table S1 ). The apo-GLTP structure was used as a search model in the molecular replacement method with AMoRe 30 . A molecular replacement electron density map calculated at 1.95 Å resolution indicated the location of protein regions involved in conformational rearrangements. The amino-acid residues that belonged to these regions were removed from the initial model and retraced de novo with ARP/wARP. The rebuilt model was then refined with REFMAC. The difference electron density map calculated on the basis of the refined protein model clearly exhibited extra density, which was manually interpreted as a bound lactosylceramide molecule. Solvent molecules were added to the model by the automatic procedure ARP/ wARP. The model was refined in REFMAC at 1.95 Å resolution to a final R-factor/R-free of 0.192/0.244. Figure 2b shows the headgroup and its interactions for a bound lactosylceramide molecule in the final 2F o 2 F c electron density map, and Supplementary  Fig. S9 displays the omit 2F o 2 F c map for a ligand. The distribution of the secondary structure elements along the amino acid sequence (Supplementary Fig. S2c ) shows distinctions from those observed for apo-GLTP (Supplementary Fig. S8c ). The final model contains two disordered regions (1-3 and 168) . The apo-GLTP and lactosylceramidebound GLTP crystals contain a small piece of unknown hydrocarbon, acquired during the expression of protein in Escherichia coli, an unsurprising situation for glycosphingolipid-binding proteins 19 . The CASTp program (http://cast.engr.uic.edu) was used to estimate solvent-accessible volumes of cavities in apo-GLTP and lactosylceramidebound GLTP.
letters to nature Non-enveloped virus particles (those that lack a lipid-bilayer membrane) must breach the membrane of a target host cell to gain access to its cytoplasm. So far, the molecular mechanism of this membrane penetration step has resisted structural analysis. The spike protein VP4 is a principal component in the entry apparatus of rotavirus, a non-enveloped virus that causes gastroenteritis and kills 440,000 children each year 1 . Trypsin cleavage of VP4 primes the virus for entry by triggering a rearrangement that rigidifies the VP4 spikes 2 . We have determined the crystal structure, at 3.2 Å resolution, of the main part of VP4 that projects from the virion. The crystal structure reveals a coiledcoil stabilized trimer. Comparison of this structure with the two-fold clustered VP4 spikes in a ,12 Å resolution image reconstruction from electron cryomicroscopy of trypsin-primed virions shows that VP4 also undergoes a second rearrangement, in which the oligomer reorganizes and each subunit folds back on itself, translocating a potential membrane-interaction peptide from one end of the spike to the other. This rearrangement resembles the conformational transitions of membrane fusion proteins of enveloped viruses [3] [4] [5] [6] . VP4 spikes on virions have 'head', 'body', 'stalk' and 'foot' regions (Fig. 1a) , formed by the two VP4 trypsin cleavage fragments VP8* and VP5* (Fig. 1b) . The VP8* fragment contains a globular domain, the 'VP8* core', which forms the head 7 . In some virus strains the VP8* core is a haemagglutination domain, which mediates initial cell attachment by binding sialic acid. Portions of both VP8* and VP5* make up the body. VP5* residues in the body are implicated in membrane penetration and integrin binding [8] [9] [10] . The carboxyterminal part of VP5* forms the foot, which is buried beneath the VP7 layer, anchoring the spike. Neutralizing antibodies against rotavirus bind VP8*, VP5* and VP7 and block cell entry 11 . When present in the gut lumen, they protect against rotavirus gastroenteritis 12 . Thus, knowledge of the structural basis for cell entry can inform vaccine development.
The VP5* fragment used for structure determination (VP5CT; Fig. 1b) is produced by serial chymotrypsin and trypsin cleavage of a VP4 precursor 13 . Expressed directly, the fragment is insoluble and probably misfolded. VP5CT has the authentic VP5* amino terminus at A248. VP4 cleavage to produce this N terminus is required to prime particles for cell entry and membrane interaction 14, 15 . The crystal structure of VP5CT contains rhesus rotavirus (RRV) VP4 residues N252-L523. Perfect hemihedral twinning prevented use of diffraction data beyond 3.2 Å resolution in the structure determination (see Methods and Supplementary Methods).
VP5CT is a well-ordered homotrimer that resembles a folded umbrella (Fig. 2a) . The 'post' of the umbrella is a C-terminal, a-helical, triple coiled-coil. Each of the three panels comprising the 'shade' of the umbrella is an N-terminal globular domain (Fig. 2b) . Each globular domain packs in a groove between the a-helices of the other two subunits on the post's negatively charged outer surface
